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ABSTRACT 
Background: The inflammatory cytokine cascade is implicated in the pathogenesis of 
necrotising enterocolitis (NEC). Genetic association studies of cytokine 
polymorphisms may help to detect molecular mechanisms that are causally related to 
the disease process. 
Aim: To examine associations between the common genetic variants in candidate 
inflammatory cytokine genes and NEC in preterm infants.  
Methods: Multi-centre case-control and genetic association study. DNA samples 
were collected from 50 preterm infants with NEC and 50 gestational-age and ethnic 
group frequency-matched controls recruited to a multi-centre case-control study. 10 
candidate single nucleotide polymorphisms (SNPs) in cytokines previously associated 
with infectious or inflammatory diseases were genotyped. The findings were included 
in random effects meta-analyses with data from previous genetic association studies. 
Results: All allele distributions were in Hardy-Weinberg equilibrium. None of the 
studied cytokine polymorphisms was significantly associated with NEC. Four 
previous genetic association studies of cytokine polymorphisms and NEC in preterm 
infants were found. Meta-analyses were possible for several SNPs. These increased 
the precision of the estimates of effect size but did not reveal any significant 
associations. 
Conclusions: The available data are not consistent with more than modest 
associations between these candidate cytokine variant alleles and NEC in preterm 
infants. Data from future association studies of these polymorphisms may be added to 
the meta-analyses to obtain more precise estimates of effects sizes. 
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BACKGROUND 
Necrotising enterocolitis (NEC) is a major cause of death and disability in preterm 
infants but its pathogenesis is incompletely understood. Gut immaturity and sub-
optimal gut perfusion, exacerbated by enteral feeding, may be important. Additional 
factors, including enteric or systemic infection, may then precipitate a cascade of 
inflammatory events leading to the clinical and pathological end-point of NEC.1 
 
Evidence exists for the involvement of the several host inflammatory mediators in the 
final common pathway leading to NEC. Plasma levels and tissue expression of pro-
inflammatory cytokines, tumour necrosis factor (TNF), interleukin (IL)-1 beta, IL-6, 
IL-8, and IL-18 are elevated in infants with NEC.2-4 Pro-inflammatory effects are 
modulated by receptor antagonists and regulation of receptors as well as by the effects 
of anti-inflammatory cytokine cascades, principally IL-10.5,6 Studies using animal 
models have suggested that modulating the inflammatory cytokine cascade may be a 
beneficial adjunctive strategy for treating preterm infants with NEC.7-9 
 
In investigating the contribution of these complex cytokine cascades to the 
pathogenesis of NEC, it is difficult to distinguish molecular mechanisms that are 
causal from those that are epiphenomena of the disease process. Elevated plasma and 
tissue levels of inflammatory mediators may be a consequence, rather than the cause, 
of the disease. An alternative strategy that obviates these problems is to examine 
whether the risk of NEC is associated with genetic factors that regulate cytokine 
production or function. This approach has been used to study the role of inflammatory 
mediators in a number of diseases associated with preterm birth, including NEC.10-12  
 
Here we have examined associations between variants in candidate cytokine genes 
with susceptibility to NEC in preterm infants recruited to a multi-centre case-control 
study. We focussed on common single nucleotide polymorphisms (SNP) that are of 
likely or proved functional significance, or have plausible disease associations 
described previously. Since genetic association studies in this field are often limited by 
small sample sizes and are underpowered to exclude modest associations, where 
possible, we have quantitatively synthesised the study findings with data from other 
studies in order to provide a more precise estimate of the effect size.13 
 
METHODS 
A case-control study of NEC in preterm infants was conducted in ten neonatal units in 
the north of Britain between January 2004 and December 2005. Briefly, cases were 
preterm infants with NEC diagnosed using modified Bell criteria or at laparotomy or 
autopsy examination. Controls were infants who had not developed NEC by 34 
weeks’ postmenstrual age. Cases and controls were frequency-matched for gestational 
age at birth. More details of the methods are published elsewhere.14 The Northern & 
Yorkshire multi-centre research ethics committee approved the study. 
 
A dried blood sample from each infant was collected on filter paper (Whatman FTA). 
DNA was extracted using the REDExtract-N-Amp Blood PCR kit (Sigma Chemicals). 
The relevant sequences were amplified by polymerase chain reaction (PCR) and the 
products sequenced in an automated sequencer using a standard SNaPshot run setup 
(see appendix for PCR SNP primer sequences, and PCR run conditions). Alleles were 
assigned with the ABI GeneMapper software and re-checked manually. Data were 
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analysed combining individuals homozygous and heterozygous for the variant allele 
into a single exposure class. 
 
Table 1. Location of candidate SNP (relative to transcription start site) 
Cytokine SNP position  
(major/minor allele) 
Putative effect of minor allele  
TNF -238 (G/A) *Increased transcription15 
TNF -308 (G/A) *Increased transcription 15,16 
IL-1 beta -31 (T/C) Decreased transcription 17  
IL-1 beta -511 (C/T)  Increased transcription 17 
IL-4 receptor alpha +1902 (G/A) Enhanced signalling 18 
IL-6 -174 (G/C) Increased production 19  
IL-8 -251 (T/A) Increased production 20 
IL-10  -1082 (G/A) Reduced transcription 21 
IL-18  -137 (G/C) Reduced transcription 22 
IL-18  -607 (C/A) Reduced transcription 22 
*cell/stimulus specific 
 
Meta-analysis 
MEDLINE (1966 - 2007) and EMBASE (1980 - 2007) were searched for genetic 
association studies using the following text words and MeSH terms: [Enterocolitis, 
Necrotizing OR necrotising enterocolitis OR NEC] AND [Polymorphism, Genetic OR 
Cytokines/genetics]. References in previous reviews and studies were examined. 
Abstracts presented at the Society for Pediatric Research and European Society for 
Pediatric Research between 1995 and 2006 were searched.  
 
For each potentially eligible study, information on setting, design, inclusion/exclusion 
criteria, and genotyping method was extracted. Study investigators were contacted to 
obtain additional information if necessary. Case-control and cohort studies were 
eligible for inclusion provided that (i) NEC was defined using standard criteria (Bell 
staging or modifications), (ii) the enrolment of participants was not made based on 
prior knowledge of genotype, (iii) genotyping had been blinded to clinical status, (iv) 
the study reported the ethnic ancestry of participants, (vi) the reported genotype 
distributions were in Hardy–Weinberg equilibrium, and (vi) the report provided data 
sufficient to calculate an odds ratio (OR). Included data were synthesised in random 
effects meta-analyses (that is, with no a priori assumption of effect homogeneity) 
using RevMan software (version 4.2). Heterogeneity was assessed using the Chi2 test 
(p < 0.1 considered significant). 
 
RESULTS 
Genetic association study 
Ten polymorphisms were genotyped in 50 cases and 50 matched controls. Allele 
distribution was in Hardy-Weinberg equilibrium for all polymorphisms. The 
proportion of infants with the variant allele did not differ significantly between cases 
and controls for any of the comparisons (table 2). The findings did not change when 
analysis was restricted to infants with stage 2/3 NEC (N=38). 
 
Systematic literature search 
Four genetic association studies of cytokine polymorphisms and NEC in preterm 
infants were found (table 3).23-29
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Table 2. Variant cytokine genotypes in cases and controls 
Allele Cases Controls OR (95% CI) 
TNF –308A  19 (38%) 17 (34%) 1.19 (0.53 to 2.69) 
TNF –238A  6 (12%) 9 (18%) 0.62 (0.20 to 1.90) 
IL-1 –31G 28 (56%) 33 (66%) 0.66 (0.29 to 1.47) 
IL-1 –511T 30 (60%) 33 (66%) 0.77 (0.24 to 1.74) 
IL-4R +1902G 15 (30%) 13 (26%) 1.22 (0.51 to 2.93) 
IL-6 –174C 37 (74%) 34 (68%) 1.34 (0.56 to 3.19) 
IL-8 –251A 36 (72%) 40 (80%) 0.64 (0.25 to 1.63) 
IL-10 –1082G 39 (78%) 38 (76%) 1.12 (0.44 to 2.84) 
IL-18 –137C 20 (40%) 25 (50%) 0.67 (0.30 to 1.47) 
IL-18 –607A 31 (62%) 30 (60%) 1.09 (0.49 to 2.43) 
 
 
Table 3. Cytokine genetic association studies in NEC. 
Reference Country and 
predominant 
ethnic groups 
Participants Design 
(cases/controls) 
Alleles studied 
23-25 Hungary-
Caucasian 
BW<1500g 
NEC= Bell 
stage I to III 
 
Case-control 
(46/90) 
TNF (-308A) 
TNF (-238A)  
IL-4 R (+1902G) 
IL-6 (-174C) 
IL-10 (-1082G) 
IL-18 (-607A) 
26 USA-Caucasian 
and African-
american 
BW<1250g 
NEC= Bell 
stage I to III 
Prospective 
cohort  
(39/102) 
 
TNF (-308A) 
TNF (-238A) 
 
 
27,28 USA-Caucasian 
and African-
american 
BW<1500g 
Mechanically 
ventilated. 
NEC= Bell 
stage I to III 
Retrospective 
cohort  
(26/262) 
TNF (-308A) 
IL-6 (-174C) 
IL-10 (-1082G) 
29 Germany-
Caucasian 
GA<32 weeks 
NEC= Bell 
stage I to III 
Retrospective 
cohort  
(9/64) 
TNF (-308A)  
IL-10 (-1082G) 
 
 
 
Meta-analyses 
TNF (-308A), TNF(-238A), IL-6 (-174C), and IL-10 (-1082A) 
Random effects meta-analyses of data from the present study with those from 
previous studies did not reveal any significant differences (figure). None of the meta-
analyses demonstrated significant heterogeneity. 
 
IL-4R (+1902G) 
The only previous study to have examined the association of IL-4R (+1902G) with 
NEC reported that the variant allele was significantly less common in cases than 
controls [cases: 10/46; controls: 37/90: OR 0.40 (95% CI 0.18 to 0.90)].25 We did not 
find any significant difference in the present study [cases: 15/50; controls: 13/50: OR 
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1.22 (95% CI 0.51 to 2.93)]. Meta-analysis of combined data did not find a significant 
association [pooled OR (95% CI): 0.66 (95% CI 0.37 to 1.18)].  
IL-18 (-607A) 
 
One study (in a post-hoc analysis) reported that the proportion of infants homozygous 
for the IL-18 (-607A) allele (AA genotype) was significantly higher in infants with 
stage III NEC [cases: 4/8; controls: 7/90: OR 11.9 (95% CI 2.4 to 57.9)].24 We did not 
find a significant difference in the present study [cases: 1/7; controls: 7/50: OR 0.77 
(95% CI 0.08 to 7.12)]. When these data were meta-analysed, the association was not 
statistically significant [pooled OR 3.36 (95% CI 0.21 to 53.6)]. 
 
DISCUSSION 
The available data suggest that these common cytokine genetic polymorphisms are 
not strongly associated with the risk of NEC in preterm infants. In most cases, the 
estimates of effect size suggest that modest effects (doubling of odds) have not been 
missed. For some associations, use of meta-analytic techniques commonly used for 
synthesising the findings of controlled trials allowed us to increase the precision of the 
estimates. Meta-analyses were possible because the studies recruited broadly similar 
populations of infants using standard case definitions of NEC as inclusion criteria. 
Controls were selected from ethnically similar populations, or data provided to allow 
stratified analysis by ethnic background to account for the potential confounding 
effect of population admixture.13 Although data were pooled from different study 
designs, we did not find statistical evidence of heterogeneity in the meta-analyses 
suggesting that these estimates are reliable.  
 
The TNF promoter polymorphisms (-308A and –238A) have been the most 
commonly studied cytokine gene variants. Our findings are consistent with those of 
three previous studies which did not detect any significant associations with 
NEC.23,24,29 Although the estimates of effect size from each individual study were 
wide, meta-analysis of all of these data suggest that if any associations do exist, they 
are likely to be very modest. This lack of association does not rule out the possibility 
that TNF and other pro-inflammatory cytokines are important in the pathogenesis of 
NEC in preterm infants. True associations may exist but with very modest effect sizes 
too small to be excluded by the available data. Alternatively, it may be that the 
candidate polymorphisms that we have studied are not directly involved in gene 
regulation, or that any functional effect is dependent on the haplotypic background for 
which neither we, nor others, have data. 
 
Meta-analysis of association studies also suggests that the common IL-6 (-174C) SNP 
is very unlikely to increase susceptibility to NEC. However, the lower bound of the 
95% CI for the OR was consistent with a modest protective effect (halving of odds). 
Evidence exists that this polymorphism increases IL-6 production in neonatal 
lymphocytes stimulated with lipopolysaccharide.17 Carriage of the variant is 
associated with protection against invasive infection in preterm infants, presumably 
by enhancing the immune response.30 While it is biologically plausible that a 
polymorphism that enhances the inflammatory response may increase the risk (or 
severity) of NEC, another possibility is that such a polymorphism may reduce the risk 
of NEC by preventing enteric or systemic infections that trigger the inflammatory 
cascade. Similarly, the IL-10 (-1082A) variant has been associated with an increase in 
susceptibility to late-onset invasive infection in preterm infants.28 Meta-analysis of data 
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from five studies did not reveal a significant association with NEC, but the upper 
bound of the 95% CI of the OR (2.6) does not exclude a modest effect size. Data from 
future association studies may be added to this meta-analysis to increase the precision of 
these estimates of effect size. 
 
Only two studies have previously reported significant associations between cytokine 
polymorphisms and NEC. Treszl and colleagues found that genetic variation in the IL-
4 receptor (+1902G) was associated with a lower risk of NEC.25 The investigators 
suggested that the enhanced production of IL-4 protected the immature 
gastrointestinal tract from inflammation and that screening for this allele would allow 
targeted surveillance and intervention to prevent NEC in at-risk infants. In the current 
study, and on meta-analysis of data from both studies, we did not find a significant 
association suggesting that such an approach is not justified at present.  
 
The same investigators reported an association between homozygosity of the IL-18 (-
607A) allele with stage III NEC.24 However, this association appears to have been the 
result of a post-hoc subgroup analysis, and therefore may have been spurious. We did 
not detect a similar effect, and meta-analysing the data suggests there to be no 
significant association with NEC. These findings support the need to confirm reports 
of genetic associations in independent populations, particularly if the first reported 
effect size is modest, derived from a post-hoc or subgroup analysis, and was detected 
as part of a larger association study where multiple comparisons were made.13  
 
Genetic association studies may be also be useful in examining the role of other 
inflammatory mediators in the pathogenesis of NEC. Candidates for further 
investigation include platelet-activating factor (PAF), a phospholipid with complex 
biological functions that may be a key mediator in the process leading to NEC, 
cyclooxygenase-2 and various forms of nitric oxide synthase that mediate the 
downstream vascular effects of the inflammatory cascade.1 Such studies should aim to 
study similar populations of infants (using standard case definitions), and employ 
measures to avoid confounding, particularly ethnic heterogeneity. The use of family-
based studies that allow multiple genetic markers to be examined without the 
possibility of confounding due to population admixture may be particularly suitable 
for investigating complex diseases of preterm infants.  
 
Competing interests 
We declare that we have no competing interests. 
 
Funding  
The study was funded by Tenovus (Scotland). The funder had no role in the 
collection, analysis, and interpretation of data, or in the writing of the report and the 
decision to submit the paper for publication. The National Perinatal Epidemiology 
Unit receives funding from the Department of Health. The views expressed in this 
publication are those of the authors and not necessarily those of the Department of 
Health. 
 
Acknowledgements 
We thank the principal investigators of the cited genetic association studies for 
providing further data for inclusion in the meta-analyses. 
 on 3 June 2008 fn.bmj.comDownloaded from 
 8
"What is already known on this topic"  
• Inflammatory cytokine cascades may play a key role in the pathogenesis of 
NEC in preterm infants 
• Genetic association studies may help distinguish causal molecular mechanisms 
from epiphenomena 
"What this study adds"  
• None of the candidate cytokine polymorphisms so far studied is significantly 
associated with NEC 
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